1240602-95-2 Usage
Uses
Used in Pharmaceutical Synthesis:
(6-Chloropyrazin-2-yl)methanol is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the development of new medications, contributing to the advancement of healthcare solutions.
Used in Agrochemical Production:
In the agrochemical sector, (6-Chloropyrazin-2-yl)methanol is utilized as an intermediate in the production of various agrochemicals. Its role in this industry is crucial for the development of effective products that support agricultural productivity and crop protection.
Used in Fine Chemicals Manufacturing:
(6-Chloropyrazin-2-yl)methanol is used as a building block in the manufacturing of fine chemicals. Its versatility in chemical reactions makes it an essential component in the creation of specialty chemicals used across different industries.
Used in Medicinal Chemistry and Drug Development:
Due to its unique properties, (6-Chloropyrazin-2-yl)methanol is employed in medicinal chemistry for drug development. It serves as a valuable precursor in the synthesis of potential therapeutic agents, aiding in the discovery and design of novel pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 1240602-95-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,0,6,0 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1240602-95:
(9*1)+(8*2)+(7*4)+(6*0)+(5*6)+(4*0)+(3*2)+(2*9)+(1*5)=112
112 % 10 = 2
So 1240602-95-2 is a valid CAS Registry Number.
1240602-95-2Relevant academic research and scientific papers
NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 1808; 2040, (2021/06/26)
The present disclosure relates to compounds of formula (I): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds as inhibitors of receptor tyrosine kinases, in particular oncogenic mutants of ErbB-receptors e.g. in the treatment of cancer.
BENZOXAZINONE DERIVATIVES AND ANALOGUES THEREOF AS MODULATORS OF TNF ACTIVITY
-
Page/Page column 43; 44, (2016/12/26)
A series of substituted 3,4-dihydro-2H-.1,4-benzoxazin-3-one derivatives, and analogues thereof, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
-
Paragraph 1152, (2015/02/18)
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
-
Page/Page column 253; 254, (2015/02/02)
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
